Explore our news and publications to discover groundbreaking research, innovative drug developments, and insightful analyses on aging and longevity. Follow our journey as we share updates and breakthroughs.
Browse a curated feed of milestones, research updates, and media coverage
The article captures how our work on Anti-Necrotic™ technology is opening new frontiers in medicine and longevity science. This recognition and progress reflects the collaboration and vision of our amazing team and partners.
LinkGevity, in partnership with Lithuania’s Delta Biosciences, has been awarded funding under the UK Space Agency’s International Bilateral Fund to prepare its first-in-class Anti-Necrotic™ therapeutic for space deployment. Building on their role in NASA’s Space Health Programme, the collaboration aims to fast-track treatments against cell death and degeneration, with potential impact on astronaut health and age-related diseases on Earth.
The article from The Observer spotlights LinkGevity’s Anti-Necrotic™ platform for its potential to prevent cell death, strengthen resilience, and promote longevity.
Stay informed about the latest seminars, talks, and other public communications of our groundbreaking research and discoveries.
Sharing insights with top evolutionary biologists and geneticists
Address at conference hosted by Johannes Gutenberg University Mainz
Dr. Kern discusses her aging research with Venki Ramakrishnan
